Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2018, Article ID 3712948, 6 pages
https://doi.org/10.1155/2018/3712948
Research Article

Integration of Family Planning Counselling to Mass Screening Campaign for Cervical Cancer: Experience from Guinea

1Regional Francophone Center for Training in the Prevention of Gynecological Cancers (CERFFO-PCG), Conakry, Guinea
2Public Health Department, Gamal Abdel Nasser University of Conakry, Conakry, Guinea

Correspondence should be addressed to D. W. A. Leno; rf.oohay@0002onelleinad

Received 31 August 2017; Revised 2 January 2018; Accepted 9 January 2018; Published 11 March 2018

Academic Editor: Curt W. Burger

Copyright © 2018 D. W. A. Leno et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, Global and Regional Estimates of the Incidence of Unsafe Abortion and Associated Mortality in 2008, Department of Reproductive Health and Research, 6th edition, 2011, http://www.who.int/reproductivehealth/publications/unsafe_abortion/9789241501118/en/.
  2. WHO, Screening as Well as Vaccination is Essential in the Fight against Cervical Cancer, 2017, http://www.who.int/reproductivehealth/topics/cancers/fight-cervical-cancer/en/.
  3. World Health Organization (WHO), Trends in Maternal Mortality: 1990 to 2008: Estimates Developed by WHO, UNICEF, UNFPA, and the World Bank, World Health Organization, Geneva, Switzerland, 2010.
  4. WHO, Unsafe Abortion: Global and Regional Estimates of the Incidence of Unsafe Abortion and Associated Mortality in 2008, World Health Organization, Geneva, Switzerland, 6th edition, 2011.
  5. L. Chola, S. McGee, A. Tugendhaft, E. Buchmann, and K. Hofman, “Scaling up family planning to reduce maternal and child mortality: the potential costs and benefits of modern contraceptive use in South Africa,” PLoS One, vol. 10, no. 6, p. e0130077, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. WHO, Family Planning/Contraception, Fact sheet, 2016, , http://www.who.int/mediacentre/factsheets/fs351/en/.
  7. M. Arbyn, R. Sankaranarayanan, R. Muwonge et al., “Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India,” International Journal of Cancer, vol. 123, no. 1, pp. 153–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. WHO, “Human papillomavirus vaccines: WHO position paper,” Weekly Epidemiological Record, vol. 84, no. 15, 2009. View at Google Scholar
  9. WHO, “Human papillomavirus vaccines: WHO position paper,” Biologicals, vol. 37, no. 5, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Bayo, F. X. Bosch, S. de Sanjosé et al., “Risk factors of invasive cervical cancer in Mali,” International Journal of Epidemiology, vol. 31, no. 1, pp. 202–209, 2002. View at Publisher · View at Google Scholar
  11. GUINEE, Enquête Démographique et de Santé et à Indicateurs Multiples (EDS-MICS 2012), Institut National de la Statistique, Ministère du Plan Conakry, Guinée, MEASURE DHS, ICF International, Calverton, MA, USA, 2013.
  12. L. Denny, M. Quinn, and R. Sankaranarayanan, “Chapter 8: screening for cervical cancer in developing countries,” Vaccine, vol. 24, no. 3, pp. S3/71–S3/77, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Sankaranarayanan, R. Wesley, S. Thara et al., “Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol’s iodine (VILI) in cervical cancer screening in Kerala, India,” International Journal of Cancer, vol. 106, no. 3, pp. 404–408, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. W. Sellors and R. Sankaranarayanan, Colposcopy and Treatment on Cervical Intraepithelial Neoplasia: A Beginners’ Manual, IARC Press, Lyon, France, 2003.
  15. H. ZurHausen, “Papillomavirus infections a major cause of human cancers,” Biochimica et Biophysica Acta, vol. 1288, no. 2, pp. F55–F78, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. F. X. Bosch, A. Lorincz, N. Munoz, C. J. Meijer, and K. V. Shah, “The causal relation between human papillomavirus and cervical cancer,” Journal of Clinical Pathology, vol. 55, no. 4, pp. 244–265, 2002. View at Publisher · View at Google Scholar
  17. S. Goldie, L. Gaffikin, J. Goldhaber-Fiebert et al., “Cost effectiveness of cervical screening in five developing countries,” New England Journal of Medicine, vol. 353, no. 20, pp. 2158–2168, 2005. View at Publisher · View at Google Scholar · View at Scopus